GLP-3 RT
A triple-agonist peptide studied for its action across three metabolic pathways simultaneously. GLP-3 RT represents the next generation of multi-receptor research in metabolic and body composition science.
Three pathways, one peptide.
GLP-3 RT, known in the research literature as retatrutide, is a synthetic peptide that activates three distinct receptors simultaneously: GLP-1, GIP, and glucagon. It is among the newest entries in the metabolic peptide family and one of the most-discussed compounds in current weight and body composition research.
Most metabolic research focuses on one pathway at a time. GLP-3 RT was designed to engage three at once — a multi-receptor approach that has produced some of the most striking results in metabolic peptide trials to date, particularly relevant to research on the metabolic shifts women experience through midlife and beyond.
Published research has documented retatrutide’s effects on appetite signaling, energy expenditure, and lipid metabolism — with results in clinical trials that have placed it at the center of next-generation metabolic peptide research.
The next generation of metabolic research.
Body Composition
Appetite & Satiety
Energy Metabolism
Independently Tested. Verified by Batch.
Labeled amount per vial
Questions.
Research Use Only
